Victory Capital Management
ACHN

Victory Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Victory Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-43,512
Closed -$262K – 3818
2019
Q4 		$262K Buy
43,512
+21,530
+98% +$125K ﹤0.01% 2244
2019
Q3 		$79K Buy
+21,982
New +$84.7K ﹤0.01% 2517

Victory Capital Management's ACHN Position: Q1 2020 in Review

Victory Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 43,512 shares — an estimated $262K sold.

Victory Capital Management first reported a position in ACHN in Q3 2019 and held it in 2 quarters. The position peaked at $262K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Victory Capital Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Victory Capital Management sold 43,512 Achillion Pharmaceuticals shares in Q1 2020, an estimated $262K.
  • Victory Capital Management first reported a position in Achillion Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Achillion Pharmaceuticals position peaked at $262K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Victory Capital Management's 13F filing for Q1 2020, filed 4 May 2020.